BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Hydroxychloroquine: risk of serious side effects when used to treat COVID-19

Active substance: hydroxychloroquine, chloroquine

The BfArM informs about the risk of serious side effects when using hydroxychloroquine for the treatment of COVID-19.

To the risk information (available in German only)

The European Medicines Agency (EMA) reminds on its website of the risk of serious side effects when using hydroxychloroquine (and chloroquine):